1. Home
  2. RDWR vs SVRA Comparison

RDWR vs SVRA Comparison

Compare RDWR & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radware Ltd.

RDWR

Radware Ltd.

HOLD

Current Price

$29.99

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Savara Inc.

SVRA

Savara Inc.

BUY

Current Price

$4.88

Market Cap

1.1B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
RDWR
SVRA
Founded
1996
2007
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2000
2009

Fundamental Metrics

Financial Performance
Metric
RDWR
SVRA
Price
$29.99
$4.88
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
★ $30.50
$10.94
AVG Volume (30 Days)
254.7K
★ 2.0M
Earning Date
10-28-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.09
N/A
Revenue Next Year
$7.92
$3,963.52
P/E Ratio
$59.76
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$21.68
$3.35
52 Week High
$32.79
$7.01

Technical Indicators

Market Signals
Indicator
RDWR
SVRA
Relative Strength Index (RSI) 54.23 40.91
Support Level $26.61 $4.77
Resistance Level $32.14 $5.53
Average True Range (ATR) 1.13 0.24
MACD 0.06 -0.04
Stochastic Oscillator 46.56 29.73

Price Performance

Historical Comparison
RDWR
SVRA

About RDWR Radware Ltd.

Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: